Published in Neurosci Lett on January 27, 2011
Decoding the signaling of a GPCR heteromeric complex reveals a unifying mechanism of action of antipsychotic drugs. Cell (2011) 2.55
Rescue of infralimbic mGluR2 deficit restores control over drug-seeking behavior in alcohol dependence. J Neurosci (2013) 1.22
The prevalence, maintenance, and relevance of G protein-coupled receptor oligomerization. Mol Pharmacol (2013) 1.14
Head-twitch response in rodents induced by the hallucinogen 2,5-dimethoxy-4-iodoamphetamine: a comprehensive history, a re-evaluation of mechanisms, and its utility as a model. Drug Test Anal (2012) 1.13
Ligand-dependent conformations and dynamics of the serotonin 5-HT(2A) receptor determine its activation and membrane-driven oligomerization properties. PLoS Comput Biol (2012) 1.10
Animal models of serotonergic psychedelics. ACS Chem Neurosci (2012) 1.03
Identification of three residues essential for 5-hydroxytryptamine 2A-metabotropic glutamate 2 (5-HT2A·mGlu2) receptor heteromerization and its psychoactive behavioral function. J Biol Chem (2012) 1.00
Psychedelics. Pharmacol Rev (2016) 1.00
GPCR oligomers in pharmacology and signaling. Mol Brain (2011) 0.94
Membrane-sensitive conformational states of helix 8 in the metabotropic Glu2 receptor, a class C GPCR. PLoS One (2012) 0.91
Characterization of the head-twitch response induced by hallucinogens in mice: detection of the behavior based on the dynamics of head movement. Psychopharmacology (Berl) (2013) 0.88
Personality, psychopathology, life attitudes and neuropsychological performance among ritual users of Ayahuasca: a longitudinal study. PLoS One (2012) 0.86
Functional significance of serotonin receptor dimerization. Exp Brain Res (2013) 0.84
Allosteric signaling through an mGlu2 and 5-HT2A heteromeric receptor complex and its potential contribution to schizophrenia. Sci Signal (2016) 0.84
Family a GPCR heteromers in animal models. Front Pharmacol (2014) 0.83
Serotonergic hallucinogens as translational models relevant to schizophrenia. Int J Neuropsychopharmacol (2013) 0.82
Functional selectivity in GPCR heterocomplexes. Mini Rev Med Chem (2012) 0.81
Psychedelics and Immunomodulation: Novel Approaches and Therapeutic Opportunities. Front Immunol (2015) 0.81
Cerebral 5-HT2A receptor binding, but not mGluR2, is increased in tryptophan hydroxylase 2 decrease-of-function mice. Neurosci Lett (2013) 0.81
Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years. Ther Adv Psychopharmacol (2016) 0.81
G protein-coupled receptor heterocomplexes in neuropsychiatric disorders. Prog Mol Biol Transl Sci (2013) 0.80
Positive allosteric modulators of metabotropic glutamate 2 receptors in schizophrenia treatment. Trends Neurosci (2015) 0.80
Repressive epigenetic changes at the mGlu2 promoter in frontal cortex of 5-HT2A knockout mice. Mol Pharmacol (2013) 0.80
Modulation of mGlu2 Receptors, but Not PDE10A Inhibition Normalizes Pharmacologically-Induced Deviance in Auditory Evoked Potentials and Oscillations in Conscious Rats. PLoS One (2016) 0.79
Interaction of psychoactive tryptamines with biogenic amine transporters and serotonin receptor subtypes. Psychopharmacology (Berl) (2014) 0.79
Classical hallucinogens as antidepressants? A review of pharmacodynamics and putative clinical roles. Ther Adv Psychopharmacol (2014) 0.79
Chronic treatment with LY341495 decreases 5-HT(2A) receptor binding and hallucinogenic effects of LSD in mice. Neurosci Lett (2013) 0.79
Preclinical models of antipsychotic drug action. Int J Neuropsychopharmacol (2013) 0.79
Clinical applications of hallucinogens: A review. Exp Clin Psychopharmacol (2016) 0.78
The Therapeutic Potentials of Ayahuasca: Possible Effects against Various Diseases of Civilization. Front Pharmacol (2016) 0.78
Serotonin 2A Receptor SNP rs7330461 Association with Treatment Response to Pomaglumetad Methionil in Patients with Schizophrenia. J Pers Med (2016) 0.78
5-HT2A and 5-HT2C receptors as hypothalamic targets of developmental programming in male rats. Dis Model Mech (2016) 0.77
Central serotonin-2A (5-HT2A) receptor dysfunction in depression and epilepsy: the missing link? Front Pharmacol (2015) 0.76
Neuropharmacology of N,N-dimethyltryptamine. Brain Res Bull (2016) 0.75
D-serine deficiency attenuates the behavioral and cellular effects induced by the hallucinogenic 5-HT(2A) receptor agonist DOI. Behav Brain Res (2013) 0.75
Neuroreceptor activation by vibration-assisted tunneling. Sci Rep (2015) 0.75
Elucidation of molecular kinetic schemes from macroscopic traces using system identification. PLoS Comput Biol (2017) 0.75
Group II Metabotropic Glutamate Receptors as Targets for Novel Antipsychotic Drugs. Front Pharmacol (2016) 0.75
Lysergic acid diethylamide: a drug of 'use'? Ther Adv Psychopharmacol (2016) 0.75
Serotonergic Suppression of Mouse Prefrontal Circuits Implicated in Task Attention. eNeuro (2016) 0.75
Pharmacokinetics of Escalating Doses of Oral Psilocybin in Healthy Adults. Clin Pharmacokinet (2017) 0.75
Ayahuasca, dimethyltryptamine, and psychosis: a systematic review of human studies. Ther Adv Psychopharmacol (2017) 0.75
A Single Dose of LSD Does Not Alter Gene Expression of the Serotonin 2A Receptor Gene (HTR2A) or Early Growth Response Genes (EGR1-3) in Healthy Subjects. Front Pharmacol (2017) 0.75
Seven-transmembrane receptors. Nat Rev Mol Cell Biol (2002) 11.50
Pharmacology and functions of metabotropic glutamate receptors. Annu Rev Pharmacol Toxicol (1997) 10.26
A review of central 5-HT receptors and their function. Neuropharmacology (1999) 6.13
G-protein-coupled receptor heterodimerization modulates receptor function. Nature (1999) 4.73
Identification of a serotonin/glutamate receptor complex implicated in psychosis. Nature (2008) 4.09
Hallucinogens. Pharmacol Ther (2004) 4.01
Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior. Neuron (2007) 2.98
Modeling madness in mice: one piece at a time. Neuron (2006) 2.60
G protein-coupled receptor hetero-dimerization: contribution to pharmacology and function. Br J Pharmacol (2009) 2.60
Glycoprotein hormone receptors: link between receptor homodimerization and negative cooperativity. EMBO J (2005) 2.16
Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action. Neuroreport (1998) 2.03
Multiplicity of mechanisms of serotonin receptor signal transduction. Pharmacol Ther (2002) 1.99
Impairment of hippocampal mossy fiber LTD in mice lacking mGluR2. Science (1996) 1.81
Efficacy at G-protein-coupled receptors. Nat Rev Drug Discov (2002) 1.76
Serotonin research: contributions to understanding psychoses. Trends Pharmacol Sci (2008) 1.75
Transcriptome fingerprints distinguish hallucinogenic and nonhallucinogenic 5-hydroxytryptamine 2A receptor agonist effects in mouse somatosensory cortex. J Neurosci (2003) 1.64
Evidence for the role of metabotropic glutamate (mGlu)2 not mGlu3 receptors in the preclinical antipsychotic pharmacology of the mGlu2/3 receptor agonist (-)-(1R,4S,5S,6S)-4-amino-2-sulfonylbicyclo[3.1.0]hexane-4,6-dicarboxylic acid (LY404039). J Pharmacol Exp Ther (2008) 1.55
The mGlu2 but not the mGlu3 receptor mediates the actions of the mGluR2/3 agonist, LY379268, in mouse models predictive of antipsychotic activity. Psychopharmacology (Berl) (2007) 1.36
Crosstalk between GABAB and mGlu1a receptors reveals new insight into GPCR signal integration. EMBO J (2009) 1.32
Psychedelics and schizophrenia. Trends Neurosci (2009) 1.32
Enhanced cocaine responsiveness and impaired motor coordination in metabotropic glutamate receptor subtype 2 knockout mice. Proc Natl Acad Sci U S A (2005) 1.30
Probing the existence of G protein-coupled receptor dimers by positive and negative ligand-dependent cooperative binding. Mol Pharmacol (2006) 1.20
Metabotropic glutamate 2/3 receptors as drug targets. Curr Opin Pharmacol (2004) 1.11
Dopamine D2 receptor dimer formation: evidence from ligand binding. J Biol Chem (2001) 1.10
Dimer-based model for heptaspanning membrane receptors. Trends Biochem Sci (2005) 1.07
Principles: a model for the allosteric interactions between ligand binding sites within a dimeric GPCR. Trends Pharmacol Sci (2005) 1.05
Group II metabotropic glutamate receptors and schizophrenia. Cell Mol Life Sci (2009) 1.04
Agonist-trafficking and hallucinogens. Curr Med Chem (2009) 1.00
A complex signaling cascade links the serotonin2A receptor to phospholipase A2 activation: the involvement of MAP kinases. J Neurochem (2003) 0.99
The evolutionarily triumphant G-protein-coupled receptor. Mol Pharmacol (2003) 0.96
Role of 5-HT2A and 5-HT2C receptors in the stimulus effects of hallucinogenic drugs. II: Reassessment of LSD false positives. Psychopharmacology (Berl) (1995) 0.95
Quantitative stoichiometry of G-proteins activated by mu-opioid receptors in postmortem human brain. Eur J Pharmacol (2002) 0.93
On the fitting of binding data when receptor dimerization is suspected. Br J Pharmacol (2008) 0.92
5HT-2 mediation of acute behavioral effects of hallucinogens in rats. Psychopharmacology (Berl) (1990) 0.91
Modeling "psychosis" in vitro by inducing disordered neuronal network activity in cortical brain slices. Psychopharmacology (Berl) (2009) 0.90
Promise of mGluR2/3 activators in psychiatry. Neuropsychopharmacology (2009) 0.88
Accuracy and calibration of commercial oligonucleotide and custom cDNA microarrays. Nucleic Acids Res (2002) 6.70
Identification of a serotonin/glutamate receptor complex implicated in psychosis. Nature (2008) 4.09
Dynamic reorganization of striatal circuits during the acquisition and consolidation of a skill. Nat Neurosci (2009) 3.38
Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior. Neuron (2007) 2.98
Influenza virus evades innate and adaptive immunity via the NS1 protein. J Virol (2006) 2.94
Decoding the signaling of a GPCR heteromeric complex reveals a unifying mechanism of action of antipsychotic drugs. Cell (2011) 2.55
Cortical 5-HT2A receptor signaling modulates anxiety-like behaviors in mice. Science (2006) 2.49
Local protein synthesis mediates a rapid increase in dendritic elongation factor 1A after induction of late long-term potentiation. J Neurosci (2005) 2.00
Focused microarray analysis. Methods (2003) 1.73
Transcriptome fingerprints distinguish hallucinogenic and nonhallucinogenic 5-hydroxytryptamine 2A receptor agonist effects in mouse somatosensory cortex. J Neurosci (2003) 1.64
flowPeaks: a fast unsupervised clustering for flow cytometry data via K-means and density peak finding. Bioinformatics (2012) 1.53
HDAC2 regulates atypical antipsychotic responses through the modulation of mGlu2 promoter activity. Nat Neurosci (2012) 1.52
Differential gene expression in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler (2011) 1.48
Monitoring G-protein-coupled receptor signaling with DNA microarrays and real-time polymerase chain reaction. Methods Enzymol (2002) 1.41
Chromosome-specific and noisy IFNB1 transcription in individual virus-infected human primary dendritic cells. Nucleic Acids Res (2007) 1.40
Maternal influenza viral infection causes schizophrenia-like alterations of 5-HT₂A and mGlu₂ receptors in the adult offspring. J Neurosci (2011) 1.36
Psychedelics and schizophrenia. Trends Neurosci (2009) 1.32
Interferon-beta pretreatment of conventional and plasmacytoid human dendritic cells enhances their activation by influenza virus. PLoS Pathog (2008) 1.32
CXC chemokine receptors on human oligodendrocytes: implications for multiple sclerosis. Brain (2005) 1.30
Early single cell bifurcation of pro- and antiapoptotic states during oxidative stress. J Biol Chem (2004) 1.24
Agonist-specific transactivation of phosphoinositide 3-kinase signaling pathway mediated by the dopamine D2 receptor. J Biol Chem (2003) 1.18
Improved compensation in flow cytometry by multivariable optimization. Cytometry A (2011) 1.15
Getting started in biological pathway construction and analysis. PLoS Comput Biol (2008) 1.14
Misty Mountain clustering: application to fast unsupervised flow cytometry gating. BMC Bioinformatics (2010) 1.13
Chronic exposure to TNF-alpha increases airway mucus gene expression in vivo. J Allergy Clin Immunol (2005) 1.13
Method for multiplex cellular detection of mRNAs using quantum dot fluorescent in situ hybridization. Nucleic Acids Res (2005) 1.12
Biphasic effects of postnatal exposure to diethylhexylphthalate on the timing of puberty in male rats. J Androl (2007) 1.11
Antiviral response dictated by choreographed cascade of transcription factors. J Immunol (2010) 1.10
Multiple testing and its applications to microarrays. Stat Methods Med Res (2009) 1.10
Research resource: Gonadotropin-releasing hormone receptor-mediated signaling network in LbetaT2 cells: a pathway-based web-accessible knowledgebase. Mol Endocrinol (2010) 1.09
Conserved helix 7 tyrosine acts as a multistate conformational switch in the 5HT2C receptor. Identification of a novel "locked-on" phenotype and double revertant mutations. J Biol Chem (2002) 1.05
Mixed analog/digital gonadotrope biosynthetic response to gonadotropin-releasing hormone. J Biol Chem (2006) 1.04
Bone morphogenetic protein 2 and activin A synergistically stimulate follicle-stimulating hormone beta subunit transcription. J Mol Endocrinol (2007) 1.04
Group II metabotropic glutamate receptors and schizophrenia. Cell Mol Life Sci (2009) 1.04
Animal models of serotonergic psychedelics. ACS Chem Neurosci (2012) 1.03
Cytokine response is determined by duration of receptor and signal transducers and activators of transcription 3 (STAT3) activation. J Biol Chem (2012) 1.03
Transcript profiling of immediate early genes reveals a unique role for activating transcription factor 3 in mediating activation of the glycoprotein hormone alpha-subunit promoter by gonadotropin-releasing hormone. Mol Endocrinol (2005) 1.02
Time and length scales of autocrine signals in three dimensions. Biophys J (2007) 1.01
Agonist-trafficking and hallucinogens. Curr Med Chem (2009) 1.00
The human herpesvirus 8 chemokine receptor vGPCR triggers autonomous proliferation of endothelial cells. J Clin Invest (2006) 1.00
Role of cell-to-cell variability in activating a positive feedback antiviral response in human dendritic cells. PLoS One (2011) 1.00
Identification of three residues essential for 5-hydroxytryptamine 2A-metabotropic glutamate 2 (5-HT2A·mGlu2) receptor heteromerization and its psychoactive behavioral function. J Biol Chem (2012) 1.00
Acute induction of gene expression in brain and liver by insulin-induced hypoglycemia. Diabetes (2005) 1.00
p53 mediates nontranscriptional cell death in dopaminergic cells in response to proteasome inhibition. J Biol Chem (2006) 0.99
Functional crosstalk and heteromerization of serotonin 5-HT2A and dopamine D2 receptors. Neuropharmacology (2011) 0.99
Structure of the GnRH receptor-stimulated signaling network: insights from genomics. Front Neuroendocrinol (2003) 0.98
BioPP: a tool for web-publication of biological networks. BMC Bioinformatics (2007) 0.98
Activation of phosphoinositide 3-kinase by D2 receptor prevents apoptosis in dopaminergic cell lines. Biochem J (2003) 0.97
Coupling of GnRH concentration and the GnRH receptor-activated gene program. Mol Endocrinol (2002) 0.95
Involvement of histone demethylase LSD1 in short-time-scale gene expression changes during cell cycle progression in embryonic stem cells. Mol Cell Biol (2012) 0.94
Genomics view of gonadotrope signaling circuits. Trends Endocrinol Metab (2004) 0.93
Different dorsal striatum circuits mediate action discrimination and action generalization. Eur J Neurosci (2012) 0.93
Immune response modeling of interferon beta-pretreated influenza virus-infected human dendritic cells. Biophys J (2010) 0.93
Signaling network of dendritic cells in response to pathogens: a community-input supported knowledgebase. BMC Syst Biol (2010) 0.92
Prenatal stress induces schizophrenia-like alterations of serotonin 2A and metabotropic glutamate 2 receptors in the adult offspring: role of maternal immune system. J Neurosci (2013) 0.92
Validated genomic approach to study differentially expressed genes in complex tissues. Neurochem Res (2002) 0.91
Epsilon-sarcoglycan immunoreactivity and mRNA expression in mouse brain. J Comp Neurol (2005) 0.90
Reduced levels of serotonin 2A receptors underlie resistance of Egr3-deficient mice to locomotor suppression by clozapine. Neuropsychopharmacology (2012) 0.90
Mining microarrays for metabolic meaning: nutritional regulation of hypothalamic gene expression. Neurochem Res (2004) 0.89
Molecular basis of partial agonism: orientation of indoleamine ligands in the binding pocket of the human serotonin 5-HT2A receptor determines relative efficacy. Mol Pharmacol (2003) 0.89
SOME STEP-DOWN PROCEDURES CONTROLLING THE FALSE DISCOVERY RATE UNDER DEPENDENCE. Stat Sin (2008) 0.89
The HIV antiretroviral drug efavirenz has LSD-like properties. Neuropsychopharmacology (2013) 0.88
Noise propagation and scaling in regulation of gonadotrope biosynthesis. Biophys J (2007) 0.87
Dysregulated 5-HT(2A) receptor binding in postmortem frontal cortex of schizophrenic subjects. Eur Neuropsychopharmacol (2012) 0.86
Microtranscriptome regulation by gonadotropin-releasing hormone. Mol Cell Endocrinol (2009) 0.86
Differential coupling of the vasopressin V1b receptor through compartmentalization within the plasma membrane. Mol Pharmacol (2008) 0.85
Heteromerization of G protein-coupled receptors: relevance to neurological disorders and neurotherapeutics. CNS Neurol Disord Drug Targets (2010) 0.84
Novel Nipah virus immune-antagonism strategy revealed by experimental and computational study. J Virol (2010) 0.84
Plato's cave algorithm: inferring functional signaling networks from early gene expression shadows. PLoS Comput Biol (2010) 0.84
Distribution of prolyl endopeptidase activities in rat and human brain. Neurochem Int (2002) 0.84
Validation of efficient high-throughput plasmid and siRNA transfection of human monocyte-derived dendritic cells without cell maturation. J Immunol Methods (2010) 0.82
Characterization of a MAPK scaffolding protein logic gate in gonadotropes. Mol Endocrinol (2011) 0.82
α₂-Adrenoceptor functionality in postmortem frontal cortex of depressed suicide victims. Biol Psychiatry (2010) 0.82
Reconstruction of regulatory networks through temporal enrichment profiling and its application to H1N1 influenza viral infection. BMC Bioinformatics (2013) 0.82
Optimized protocol for efficient transfection of dendritic cells without cell maturation. J Vis Exp (2011) 0.82
G proteins and autocrine signaling differentially regulate gonadotropin subunit expression in pituitary gonadotrope. J Biol Chem (2012) 0.81
Persistent effects of chronic clozapine on the cellular and behavioral responses to LSD in mice. Psychopharmacology (Berl) (2012) 0.81
Mouse dendritic cell (DC) influenza virus infectivity is much lower than that for human DCs and is hemagglutinin subtype dependent. J Virol (2012) 0.81
Time resolved FRET strategy with fluorescent ligands to analyze receptor interactions in native tissues: application to GPCR oligomerization. Methods Mol Biol (2011) 0.80
β-catenin regulates GnRH-induced FSHβ gene expression. Mol Endocrinol (2012) 0.80
Repressive epigenetic changes at the mGlu2 promoter in frontal cortex of 5-HT2A knockout mice. Mol Pharmacol (2013) 0.80
G protein-coupled receptor heterocomplexes in neuropsychiatric disorders. Prog Mol Biol Transl Sci (2013) 0.80